HealthBusiness
Awaiting Breakthrough for Uptrend–Sunzen Biotech
Sunzen Biotech (KLSE: 0148) is poised for a breakout for the continued uptrend beyond RM0.350, the key resistance level for the company. Both MA20/50 showed positive strengths with reduced selling pressure. Key support remained at RM0.345, which was formed after multi tests on the consolidation phase. Maintain BUY for Sunzen Biotech.
Support: RM0.345, RM0.320
Resistance: RM0.350, RM0.370
More articles on HealthBusiness
A New Additional Into My Portfolio - Sunzen Biotech's Transformation and Growth
Created by Wixson | Jul 15, 2024
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
BFM Podcast
2
CGS-CIMB Research
Genting Plantations - Proposed Land Acquisition in Indonesia
3
4
Koon Yew Yin's Blog
6
save malaysia!
8
THE INVESTMENT APPROACH OF CALVIN TAN
TSH RESOURCES (9059) VERSUS JOHOR PLANTATION GROUP (5323) Compare & Contrast, Calvin Tan
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
MQ Trading Signals
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
